Literature DB >> 24385079

Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.

Min-Chieh Ho1, Wei-Cherng Hsu2, Yi-Ting Hsieh2.   

Abstract

IMPORTANCE: Botulinum toxin injection for lateral canthal rhytids has been reported to result in dry eye, but its effect on tear film stability and tear production has not been studied thoroughly.
OBJECTIVE: To investigate the effect of botulinum toxin type A on tear film stability and tear production after treatment of lateral canthal rhytids. DESIGN, SETTING, AND PARTICIPANTS: We performed a clinical intervention study at a regional hospital in Taiwan of 58 women 30 to 60 years of age with lateral canthal rhytids from January 1 through December 31, 2011.
INTERVENTIONS: Botulinum toxin type A at 2 different preparations and doses (dose A: 3 injections of 2 U in 0.05 mL of normal saline per injection; dose B: 3 injections of 4 U in 0.05 mL of normal saline per injection) was injected at the lateral canthal areas. One eye of each study participant was randomly chosen for dose A, and the other eye received dose B. MAIN OUTCOMES AND MEASURES: Baseline tear film break-up time (TBUT) and Schirmer tests without and with anesthesia were measured before and at 1 week, 1 month, 3 months, and 6 months after botulinum toxin injection. The TBUT and Schirmer test results were compared between different periods and doses.
RESULTS: The TBUT decreased significantly at 1 week after botulinum toxin type A injection (P = .003), and the effect persisted at 1 month and 3 months after treatment (P = .01 and .02, respectively). In younger participants, the TBUT recovered faster than in older patients. The results of the Schirmer tests without and with anesthesia decreased gradually, with significant reduction at 1 month after treatment (P = .05 and .02, respectively) and then recovered gradually. Both the TBUT and Schirmer test results decreased more in eyes that received dose B than in those that received dose A; however, none of the differences were statistically significant. CONCLUSIONS AND RELEVANCE: Tear film stability decreased as early as 1 week after botulinum toxin type A treatment for lateral canthal rhytids, and the effect persisted for more than 3 months. Tear production decreased to the trough at 1 month after treatment and then recovered gradually.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24385079     DOI: 10.1001/jamaophthalmol.2013.6243

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  7 in total

1.  Current practice trends for lacrimal gland neurotoxin in the management of epiphora-a BOPSS survey.

Authors:  Micheal A O'Rourke; Paul S Cannon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-18       Impact factor: 3.117

2.  Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm.

Authors:  Neslihan Bayraktar Bilen; Şule Bilen; Pınar Topçu Yılmaz; Özlem Evren Kemer
Journal:  Int Ophthalmol       Date:  2022-03-30       Impact factor: 2.029

3.  Acrylamide inhibits nerve sprouting induced by botulinum toxin type A.

Authors:  Hong Jiang; Yi Xiang; Xingyue Hu; Huaying Cai
Journal:  Neural Regen Res       Date:  2014-08-15       Impact factor: 5.135

Review 4.  Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration.

Authors:  Mark Nestor; Glynis Ablon; Andy Pickett
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

5.  Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.

Authors:  Ren-Wen Ho; Po-Chiung Fang; Tsai-Ling Chao; Chun-Chih Chien; Ming-Tse Kuo
Journal:  Sci Rep       Date:  2018-05-30       Impact factor: 4.379

Review 6.  A Review of Periocular Botulinum Neurotoxin on the Tear Film Homeostasis and the Ocular Surface Change.

Authors:  Ren-Wen Ho; Po-Chiung Fang; Cheng-Hsien Chang; Yu-Peng Liu; Ming-Tse Kuo
Journal:  Toxins (Basel)       Date:  2019-01-24       Impact factor: 4.546

7.  Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study.

Authors:  Marco Pellegrini; Costantino Schiavi; Leonardo Taroni; Stefano Sebastiani; Federico Bernabei; Matilde Roda; Fabiana Moscardelli; Giuseppe Giannaccare
Journal:  Indian J Ophthalmol       Date:  2019-09       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.